MILLISERT

Welcome to the Brand page for “MILLISERT”, which is offered here for Drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of ocular diseases and conditions, uveitis, retinal vein occlusion, macular edema, macular disease, retinal disease, and glaucoma; pharmaceutical preparations for the treatment of ocular diseases and conditions, uveitis, retinal vein occlusion, macular edema, macular disease, retinal disease, and glaucoma;sustained drug delivery systems for ocular drugs;.

Its status is currently believed to be active. Its class is unavailable. “MILLISERT” is believed to be currently owned by “EYEPOINT PHARMACEUTICALS US, INC.”